Gain of chromosome 1q21 can increase MCL1 expression, which may let leukemic cells survive BCL2 inhibition. Gain of 2p, ...

Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation ...

Liver transplantation is often the last and best hope for patients whose livers have failed, but the surgery is only the ...

A joint team of researchers at Bar-Ilan University and the Weizmann Institute has used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize ...

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through two separate detection systems. In mice, a single dose controlled cancer ...

Novartis implemented halt after three cases of life-threatening immune reaction, cancer studies not affected Swiss drugmaker working with independent safety boards to review patient deaths Bristol ...

Since both Novartis’ and Bristol Myers Squibb’s assets were developed using rapid manufacturing platforms, analysts from William Blair suggested, "that rapid manufacturing could be driving increased ...

A new study published in Nature Communications is drawing attention to a sensitive molecular approach for tracking measurable residual disease in T-cell acute lymphoblastic leukemia, or T-ALL, a ...

A new Phase I clinical trial has found that an emerging immunotherapy is promising for the treatment of recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T ...

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848 In the phase Ia/b TRAVERSE trial ...

Autologous CD19 CAR T products (tisagenlecleucel, axicabtagene ciloleucel, lisocabtagene maraleucel, brexucabtagene autoleucel) show high response rates across ALL and NHL, now including second-line ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell. This breakthrough in synthetic biology could usher in an era of ...